Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia

Proton pump inhibitors (PPI) are among the most widely prescribed drugs to treat gastric acid-related disorders. PPI-induced hypomagnesaemia, a defect in intestinal absorption of Mg(2+) , can be a severe side effect of chronic PPI use.To restore serum Mg(2+) concentrations in PPI-induced hypomagnesaemia patients by dietary supplementation with inulin fibres.Eleven patients with PPI-induced hypomagnesaemia and 10 controls were treated with inulin (20 g/day). Each trial consisted of two cycles of 14-day inulin treatment followed by a washout period of 14 days. Patients continued to use their PPI. Serum Mg(2+) levels served as the primary endpoint.Inulin significantly enhanced serum Mg(2+) levels from 0.60 to 0.68 mmol/L in PPI-induced hypomagnesaemia patients, and from 0.84 to 0.93 mmol/L in controls. As a consequence 24 h urinary Mg(2+) excretion was significantly increased in patients with PPI-induced hypomagnesaemia (0.3-2.2 mmol/day). Symptoms related to hypomagnesaemia, including muscle cramps and paraesthesia, were reduced during intervention with inulin. Inulin increases serum Mg(2+) concentrations under PPI maintenance in patients with PPI-induced hypomagnesaemia

Elite long jumpers with below the knee prostheses approach the board slower, but take-off more effectively than non-amputee athletes

Abstract The use of technological aids to improve sport performance (‘techno doping’) and inclusion of Paralympic athletes in Olympic events are matters of ongoing debate. Recently, a long jumper with a below the knee amputation (BKA) achieved jump distances similar to world-class athletes without amputations, using a carbon fibre running-specific prosthesis (RSP). We show that athletes with BKA utilize a different, more effective take-off technique in the long jump, which provided the best athlete with BKA a performance advantage of at least 0.13 m compared to non-amputee athletes. A maximum speed constraint imposed by the use of RSPs would indicate a performance disadvantage for the long jump. We found slower maximum sprinting speeds in athletes with BKA, but did not find a difference in the overall vertical force from both legs of athletes with BKA compared to non-amputees. Slower speeds might originate from intrinsically lower sprinting abilities of athletes with BKA or from more complex adaptions in sprinting mechanics due to the biomechanical and morphological differences induced by RSPs. Our results suggest that due to different movement strategies, athletes with and without BKA should likely compete in separate categories for the long jump